Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00657475
PHASE4

Coronary Bypass and Artotic Leaflet Surgery : Heparin Low Dose vs Full Dose

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

The purpose of this study is to demonstrate superiority on postoperative bleeding from the use of a heparin half dose compared to a conventional dose, under mini-extra corporeal circulation, without increased risk to the patient.

Official title: A Prospective Study of Coronary Artery Bypass Graft and/or Aortic Valve Replacement With Conventional Versus Half Heparin Dose Under Closed and Coated Extra Corporeal Circulation System (MECC) - APPACHES Study.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

238

Start Date

2008-06

Completion Date

2013-03

Last Updated

2026-05-19

Healthy Volunteers

No

Interventions

DRUG

Heparin Low Dose

Loading heparin dose of 150 IU / kg to achieve an ACT (activating clotting time) target more than 240 seconds.

DRUG

Heparin Full Dose

Loading heparin dose of 300 IU / kg to achieve an ACT (activating clotting time) target more than 400 seconds.

Locations (1)

Cardiac Surgery Dpt (University Hospital)

Bordeaux, France